Published in ZWR on October 25, 1978
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
A world without mangroves? Science (2007) 6.13
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia (2002) 3.90
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell (1993) 3.57
Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene (1993) 2.19
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res (2001) 2.06
Multiple correlations and Bonferroni's correction. Biol Psychiatry (1998) 1.69
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia (1999) 1.55
Intramedullary pressure and bone marrow fat extravasation in reamed and unreamed femoral nailing. J Orthop Res (1999) 1.53
Biocomplexity in mangrove ecosystems. Ann Rev Mar Sci (2010) 1.48
Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46
Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol (1995) 1.45
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. J Clin Oncol (1986) 1.39
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Leukemia (2003) 1.37
Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36
Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet (1989) 1.36
Sexual practices among patients with borderline personality disorder. Am J Psychiatry (1987) 1.34
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha. Leukemia (2002) 1.31
Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol (1989) 1.29
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet (1999) 1.28
Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24
Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23
[Menigitis due to Moraxella osloensis (author's transl)]. Infection (1974) 1.21
Fine structure and taxonomic position of Neisseria haemolysans (Thjotta and Boe 1938) or Gemella haemolysans (Berger 1960). Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.20
Rates and odds ratios for complications in closed and open tibial fractures treated with unreamed, small diameter tibial nails: a multicenter analysis of 467 cases. J Orthop Trauma (2001) 1.18
ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt. J Biol Chem (1991) 1.18
Capsella embryogenesis: the chalazal proliferating tissue. J Cell Sci (1971) 1.17
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecol Oncol (2001) 1.16
[Some properties of carrier strains of Listeria monocytogenes (author's transl)]. Med Microbiol Immunol (1975) 1.15
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia (2003) 1.11
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin Cancer Res (2001) 1.10
Differentiation of Gemella haemolysans (Thjøtta and Bøe 1938) Berger 1960, from Streptococcus morbillorum (Prevot 1933) Holdeman and Moore 1974. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 1.09
Ubiquinone biosynthesis. Cloning of the genes coding for chorismate pyruvate-lyase and 4-hydroxybenzoate octaprenyl transferase from Escherichia coli. FEBS Lett (1992) 1.06
Simple assay of 0.1-1.0 pmol of ATP, ADP, and AMP in single somatic cells using purified luciferin luciferase. Anal Biochem (1981) 1.06
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer (1999) 1.05
[Acetazolamide-resistance as a taxonomic criterion of Neisseria]. Arch Hyg Bakteriol (1971) 1.05
Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J (Clin Res Ed) (1988) 1.04
Partial purification and properties of geranyl pyrophosphate synthase from Lithospermum erythrorhizon cell cultures. Arch Biochem Biophys (1989) 1.03
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res Treat (1999) 1.03
Prevalence of Gemella haemolysans on the pharyngeal mucosa of man. Med Microbiol Immunol (1985) 1.02
Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia (2000) 1.02
Geographic and temporal variations in pollen exposure across Europe. Allergy (2014) 1.01
Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer. Cancer Res (1987) 0.99
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up. Br J Cancer (1999) 0.98
Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol (1988) 0.98
New chromosomal malformation syndromes. I. Partial monosomy 8p. An attempt to establish a new chromosome deletion syndrome. Eur J Pediatr (1977) 0.97
Comparison of two endotracheal tube securement techniques on unplanned extubation, oral mucosa, and facial skin integrity. Heart Lung (1999) 0.97
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood (1996) 0.96
Historical trends in persistent organic pollutants and metals recorded in sediment from Lake Ellasjøen, Bjørnøya, Norwegian Arctic. Environ Pollut (2006) 0.96
Distribution of herpes simplex virus type 1 in human geniculate and vestibular ganglia: implications for vestibular neuritis. Ann Neurol (1999) 0.96
Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol Endocrinol (1992) 0.95
The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol (1989) 0.95
Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol (1998) 0.95
Effects of H1-receptor antagonists on nasal obstruction in atopic patients. Allergy (1993) 0.95
Distribution of serotypes of Neisseria meningitidis in the Federal Republic of Germany, 1979-1981. Med Microbiol Immunol (1982) 0.94
Detection of herpes simplex virus type 1 in human vestibular nuclei. Neurology (2000) 0.94
[Increasing regional disparities in living conditions in Germany and their role in the explanation of health inequalities]. Gesundheitswesen (2009) 0.93
Airborne olive pollen counts are not representative of exposure to the major olive allergen Ole e 1. Allergy (2013) 0.93
Intramedullary pressure and bone marrow fat intravasation in unreamed femoral nailing. J Trauma (1997) 0.92
Anti-labyrinthine antibodies in a patient with relapsing polychondritis. Eur Arch Otorhinolaryngol (1999) 0.92
[Self-assessment of BMI data : verification of the practicability of a correction formula on a sample of 11- to 13-year-old girls]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.91
Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol (1992) 0.91
[Distribution of species of Moraxella and moraxella-like organisms in the nasopharynx of healthy human adults (author's transl]. Med Microbiol Immunol (1976) 0.90
Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther (1983) 0.90
Interferon alpha in the treatment of polycythemia vera. Ann Hematol (2000) 0.90
Capsella embryogenesis: the central cell. J Cell Sci (1973) 0.90
Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia (2005) 0.89
Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer. Cancer Res (1986) 0.89
Alternating episodes of vestibular nerve excitation and failure. Neurology (1998) 0.89
Tissue expansion in pig skin--a histochemical approach. Anat Histol Embryol (1992) 0.88
[Reduction of nitrate and nitrite by Neisseria gonorrhoeae and Neisseria meningitidis]. Z Med Mikrobiol Immunol (1970) 0.88
First isolation of Neisseria polysacchareae species nova in the Federal Republic of Germany. Eur J Clin Microbiol (1985) 0.87
Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP. Br J Cancer (1991) 0.87
Partial purification, properties, and kinetic studies of UDP-glucose:p-hydroxybenzoate glucosyltransferase from cell cultures of Lithospermum erythrorhizon. Arch Biochem Biophys (1991) 0.87
Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo. Eur J Biochem (1990) 0.87
[Neisseria mucosa var. heidelbergensis]. Z Med Mikrobiol Immunol (1971) 0.87
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer. Int J Biol Markers (2000) 0.87
Headache cessation by an educational intervention in grammar schools: a cluster randomized trial. Eur J Neurol (2014) 0.86
High-pressure liquid chromatographic determination of amitriptyline and its major metabolites in human whole blood. J Pharm Sci (1982) 0.86
Acute action of DSP-4 on central norepinephrine axons: biochemical and immunohistochemical evidence for differential effects. J Histochem Cytochem (1989) 0.86
Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia (2003) 0.85
[Endocarditis lenta caused by Lactobacillus salivarius subsp. salicinicus (author's transl)]. Dtsch Med Wochenschr (1976) 0.84
Brominated flame retardants and other organobromines in Norwegian predatory bird eggs. Chemosphere (2005) 0.84
Immunohistochemistry of porcine skin. Acta Histochem (1991) 0.84
Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest (2001) 0.84
Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinet (1985) 0.83
ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia. Blood (2001) 0.83
Quantification of conjunctival vascular reaction by digital imaging. J Allergy Clin Immunol (1996) 0.83
Expression of ionotropic glutamate receptor subunit mRNAs by paraventricular corticotropin-releasing factor (CRF) neurons. Neurosci Lett (1996) 0.83
Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol (1992) 0.82
Cogan's syndrome: clinical significance of antibodies against the inner ear and cornea. Acta Otolaryngol (1999) 0.82
Insertion of ventilation tubes into the medical ear: results and complications. A seven-year review. Ann Otol Rhinol Laryngol Suppl (1981) 0.82
Complications in laparoscopic myomectomy. Surg Endosc (2006) 0.82
Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone. Br J Cancer (1992) 0.81